Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of our study is to investigate the effects of cervical stabilization exercise training applied with telerehabilitation in individuals with migraine.
Cervical muscles are adversely affected in individuals with migraine. It is important to investigate the effects of cervical muscle training in these individuals. Telerehabilitation applications have been used frequently in many patients in recent years. It is necessary to examine the effects of cervical stabilization exercises applied with telerehabilitation in individuals with migraine.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Exercise group | Experimental | Exercise group will be performed cervical stabilization exercise training applied with telerehabilitation and standard treatment ( preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine) for 8 weeks |
|
| Standard treatment group | Active Comparator | Standard treatment group will be given preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine for 8 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cervical Stabilization Exercise | Other | Exercise group will be performed cervical stabilization exercise training applied with telerehabilitation and standard treatment ( preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine) for 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| The characteristic of the migraine | The characteristic of the migraine will be evaluated with the "Headache Diary". | change from baseline at 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Cervical range of motion | Cervical range of motion was evaluated using the goniometer | change from baseline at 8 weeks |
| Upper cervical region movements | Upper cervical region movements will be evaluated with a Cervical Range of Motion device |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Seyda Toprak Celenay | Contact | +90312 906 1000 | sydtoprak@hotmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Seyda Toprak Celenay | Ankara Yildirim Beyazıt University | Principal Investigator |
Not provided
Not provided
| ID | Term |
|---|---|
| D008881 | Migraine Disorders |
| ID | Term |
|---|---|
| D051270 | Headache Disorders, Primary |
| D020773 | Headache Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Standard treatment | Other | standard treatment will include preventive/symptomatic oral drug therapy routinely in the clinic and suggestions for triggering factors in migraine for 8 weeks |
|
| change from baseline at 8 weeks |
| Performance of the deep neck flexor muscles | Performance of the deep neck flexor muscles will be evaluated with a Stabilizer Pressure Biofeedback Unit | change from baseline at 8 weeks |
| Cranio-vertebral angle | The cranio-vertebral angle will be measured with a goniometer | change from baseline at 8 weeks |
| Disability Status | The Turkish version of Migraine Disability Assessment Scale will be used to determine the disability status in daily activities of individuals due to migraine | change from baseline at 8 weeks |
| Sleep quality | Sleep quality will be evaluated with the Turkish version of Jenkins Sleep Scale | change from baseline at 8 weeks |
| Life quality | Life quality will be evaluated with the Turkish version of Headache Impact Test | change from baseline at 8 weeks |
| D009422 | Nervous System Diseases |